Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • uqdipgao
    Junior Member
    • Oct 2013
    • 6

    PhD Scholarship - Bioinformatics

    The successful Scholar will pursue a PhD degree in bioinformatics using next generation sequencing data to study the genetic landscape of Squamous cell carcinoma (SCC) and the relationship between UV damaged skin, Actinic keratosis (AK) and SCC.

    The Project

    A dataset of 125 exomes derived from between and within patient samples will be used to study the genetic landscape of Squamous cell carcinoma (SCC) and the relationship between UV damaged skin, Actinic keratosis (AK) and SCC.

    The candidate will develop algorithms to perform quality control of sequence data and methods to capture a comprehensive set of mutations in these samples. Methods to control of false positives and coincidental findings will be developed using a resource of 2000 control exomes that have been sequenced at The University of Queensland Centre for Clinical Genomics (UQCCG).

    The candidate will then develop statistical methods to search for biomarkers that can be used to identify the transition between tumour states and study the heterogeneity between tumours using SNPs, structural variations and copy number information. The project will be performed in collaboration with the Genomic Medicine program and Cancer program at UQDI.

    This analysis will require the use of high performance computing and programming in R and Perl.

    The Person

    The candidate will have a 1st Class Honours degree or equivalent in science, and should be eligible for an Australian Postgraduate Award (APA) or University of Queensland Research Scholarship (UQRS). We will consider students from a wide range of backgrounds, including: mathematics, statistics, epidemiology, computer science, bioinformatics, physics, genetics, and molecular biology. Applicants should be fluent in English.

    Remuneration

    The base stipend will be at the rate of AUD$25, 392 per annum tax-free for three years with the possibility of a six month extension in approved circumstances. Top-up salary may be available to suitably qualified candidates.

    Apply at http://uqjobs.uq.edu.au/jobDetails.a...W&sLanguage=en

Latest Articles

Collapse

  • mylaser
    Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by mylaser
    Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
    If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
    This guide explains everything you need to know about...
    Today, 01:13 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-08-2026, 10:08 AM
0 responses
10 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-07-2026, 11:05 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-02-2026, 11:08 AM
0 responses
31 views
0 reactions
Last Post SEQadmin2  
Working...